OPKO Health Inc
OPK1.190USD
-0.000-0.01%
交易中 （美東）報價延遲15分鐘
927.86M總市值
虧損本益比TTM
關於 OPKO Health Inc 公司
OPKO Health, Inc. 是一家跨國生物製藥和診斷公司。該公司專注於利用其發現、開發和商業化專業知識以及新穎的專有技術。其部門包括製藥和診斷。製藥部門包括其在智利、墨西哥、愛爾蘭、以色列和西班牙的製藥業務、Rayaldee 產品銷售及其製藥研發。診斷部門主要包括即時診斷業務。其製藥業務包括 Rayaldee，一種經美國食品藥品管理局 (FDA) 批准的治療患有三期或四期慢性腎病 (CKD) 和維生素 D 不足的成人繼發性甲狀旁腺功能亢進症 (SHPT) 的藥物，以及 Somatrogon (hGH-CTP)，一種每週注射一次的人類生長激素注射劑。其 NGENLA (somatrogon-ghla) 是一種每週注射一次的人類生長激素類似物，適用於治療三歲及以上的兒科患者。
公司簡介
公司代碼OPK
公司名稱OPKO Health Inc
上市日期Nov 02, 1995
CEODr. Tony F. Cruz, Ph.D.
員工數量2997
證券類型Ordinary Share
年結日Nov 02
公司地址- -
城市- -
上市交易所NASDAQ Global Select Consolidated
國家- -
郵編- -
電話- -
網址- -
公司代碼OPK
上市日期Nov 02, 1995
CEODr. Tony F. Cruz, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Jane H. Hsiao, Ph.D.
Dr. Jane H. Hsiao, Ph.D.
Vice Chairman of the Board, Chief Technical Officer
Vice Chairman of the Board, Chief Technical Officer
33.13M
--
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Executive Vice President - Administration, Director
Executive Vice President - Administration, Director
6.19M
-6.60%
Mr. John A. Paganelli
Mr. John A. Paganelli
Independent Director
Independent Director
393.51K
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
179.16K
-70.95%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
-84.80%
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Independent Director
Independent Director
66.49K
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Dr. Tony F. Cruz, Ph.D.
Dr. Tony F. Cruz, Ph.D.
Chief Executive Officer, Transition Therapeutics, Inc
Chief Executive Officer, Transition Therapeutics, Inc
--
--
Dr. Roger J. Medel, M.D.
Dr. Roger J. Medel, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Jane H. Hsiao, Ph.D.
Dr. Jane H. Hsiao, Ph.D.
Vice Chairman of the Board, Chief Technical Officer
Vice Chairman of the Board, Chief Technical Officer
33.13M
--
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Executive Vice President - Administration, Director
Executive Vice President - Administration, Director
6.19M
-6.60%
Mr. John A. Paganelli
Mr. John A. Paganelli
Independent Director
Independent Director
393.51K
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
179.16K
-70.95%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
-84.80%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
United States
116.21M
77.50%
Chile
14.53M
9.69%
Spain
6.44M
4.29%
Mexico
6.23M
4.15%
Ireland
5.48M
3.65%
Other
1.06M
0.71%
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Frost Gamma Investments Trust
27.69%
Rubric Capital Management LP
6.02%
Holbrook (Bruce C)
5.09%
Hsiao (Jane H)
4.17%
Frost Group, L.L.C.
3.80%
Other
53.23%
持股股東
持股股東
佔比
Frost Gamma Investments Trust
27.69%
Rubric Capital Management LP
6.02%
Holbrook (Bruce C)
5.09%
Hsiao (Jane H)
4.17%
Frost Group, L.L.C.
3.80%
Other
53.23%
股東類型
持股股東
佔比
Corporation
36.58%
Hedge Fund
12.09%
Investment Advisor
10.34%
Individual Investor
10.23%
Investment Advisor/Hedge Fund
6.18%
Research Firm
1.84%
Bank and Trust
0.16%
Sovereign Wealth Fund
0.14%
Pension Fund
0.12%
Other
22.32%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
470
616.50M
77.74%
-1.20M
2025Q1
498
645.32M
88.41%
+25.74M
2024Q4
501
573.04M
84.80%
-7.63M
2024Q3
497
562.18M
81.01%
-12.00M
2024Q2
501
553.77M
79.70%
+8.59M
2024Q1
492
531.83M
76.52%
-21.84M
2023Q4
493
533.01M
69.65%
+31.42M
2023Q3
496
529.79M
69.24%
+23.70M
2023Q2
502
536.53M
70.13%
+25.42M
2023Q1
520
541.69M
71.63%
+67.95M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Frost Gamma Investments Trust
219.80M
27.72%
-26.90M
-10.90%
Apr 10, 2025
Rubric Capital Management LP
48.71M
6.14%
--
--
Mar 31, 2025
Holbrook (Bruce C)
40.38M
5.09%
--
--
Feb 24, 2025
Hsiao (Jane H)
33.13M
4.18%
--
--
Apr 02, 2025
Frost Group, L.L.C.
30.13M
3.8%
--
--
Apr 02, 2025
The Vanguard Group, Inc.
29.42M
3.71%
+293.74K
+1.01%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
24.77M
3.12%
-514.39K
-2.03%
Mar 31, 2025
GJN 2021 Trust
19.91M
2.51%
--
--
Feb 24, 2025
EGN 2021 Trust
19.91M
2.51%
--
--
Feb 24, 2025
Sculptor Capital Management, Inc
12.72M
1.6%
+12.72M
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
SPDR S&P Health Care Services ETF
0.69%
Invesco NASDAQ Future Gen 200 ETF
0.44%
Amplify Weight Loss Drug & Treatment ETF
0.22%
VanEck Israel ETF
0.14%
iShares U.S. Healthcare Providers ETF
0.09%
Humankind US Stock ETF
0.09%
Vanguard US Momentum Factor ETF
0.08%
Invesco RAFI US 1500 Small-Mid ETF
0.05%
iShares Biotechnology ETF
0.05%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.05%
查看更多
SPDR S&P Health Care Services ETF
佔比0.69%
Invesco NASDAQ Future Gen 200 ETF
佔比0.44%
Amplify Weight Loss Drug & Treatment ETF
佔比0.22%
VanEck Israel ETF
佔比0.14%
iShares U.S. Healthcare Providers ETF
佔比0.09%
Humankind US Stock ETF
佔比0.09%
Vanguard US Momentum Factor ETF
佔比0.08%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.05%
iShares Biotechnology ETF
佔比0.05%
iShares MSCI USA Small-Cap Min Vol Factor ETF
佔比0.05%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
